Ante-partum haemorrhage: an update.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Emergency Medicine

Background:

• Ante-partum haemorrhage (APH) is a leading cause of maternal and fetal morbidity and mortality.
• Despite advancements in obstetric care and transfusion services, APH continues to pose significant risks.
• APH is defined as vaginal bleeding occurring from the 20th week of gestation until delivery.

Purpose of the Study:

• To highlight the critical importance of initial resuscitation and accurate diagnosis in managing APH.
• To discuss the primary causes of APH, including placenta previa and abruption.
• To emphasize the increasing incidence of placenta previa and placenta accreta, linked to rising cesarean section rates.

Main Methods:

• Review of current obstetric practices and diagnostic tools for APH.
• Emphasis on the role of ultrasound, particularly transvaginal scans, in diagnosing placenta previa.
• Discussion on the necessity of established and regularly updated protocols for managing massive hemorrhage.

Main Results:

• Placenta previa and placental abruption are the most frequent causes of APH, accounting for over half of all cases.
• Diagnostic challenges persist in some APH cases, despite comprehensive investigations.
• Transvaginal ultrasound has significantly improved the definitive diagnosis and management of placenta previa.

Conclusions:

• Effective management of APH requires a dual focus on immediate resuscitation and precise diagnosis.
• The increasing rates of cesarean deliveries correlate with a rise in placenta previa and placenta accreta.
• Implementing and rehearsing clear, updated protocols for massive hemorrhage management is essential for all obstetric units.